Pharmaceutical Technology on MSN

QIAGEN and NVIDIA partner on AI drug discovery

The integration helps researchers understand disease biology and uncover biomarkers for developing new medicines.
Hit identification and hit validation represent distinct but connected stages of early drug discovery. This article examines how HTS, hit triage, and validation assays reduce false positives and ...
Organoid screening has emerged as one of the most significant methodological advances in preclinical drug discovery, offering three-dimensional, self-organizing cellular architectures that more ...
DNA-encoded libraries have numerous advantages over traditional screening methods, including easy identification of compounds and the large quantity of compounds that can be screened simultaneously.
The genome is more than a linear code; it is a dynamic structure whose three-dimensional folding dictates how genes are regulated. Traditional sequencing technologies capture base-level variation but ...
The Discovery & Legal Technology Association (DLTA), the professional association representing electronic discovery service providers dedicated to advancing best practices, innovation, and excellence ...